Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

NCT01363609 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Type 2 Diabetes

Interventions

DRUG: Liraglutide treatment 12 weeks
DRUG: insulin glargine treatment
DRUG: GLP-1 receptor antagonist

Sponsor

Amsterdam UMC, location VUmc